---
title: "Genetic loci linked to cocaine use identified by epistasis-focused haplotype analysis"
id: "medrxiv-10-genetic-loci-associated-with-cocaine-use-identified-using-a-novel-approach-to"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-10-genetic-loci-associated-with-cocaine-use-identified-using-a-novel-approach-to"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.13.26365448v1?rss=1"
published_at: "2026-10-14T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Genetic loci linked to cocaine use identified by epistasis-focused haplotype analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-10-genetic-loci-associated-with-cocaine-use-identified-using-a-novel-approach-to
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.13.26365448v1?rss=1)
- **Published At:** 2026-10-14T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study targeted **cocaine use disorder** genetics by focusing on epistasis and haplotypes rather than single SNPs, using eQTL SNPs to build networks. - Investigators applied a custom correlation coefficient in the BlocBuster pipeline to construct allele networks from regulatory variants and tested those networks for association with cocaine use. - The discovery cohort comprised 7,826 individuals with opioid use disorder; analyses identified 12 significant haplotype associations across two ancestries. - For one associated haplotype, raw genotyping array intensity data indicated a copy number increase at the **CYP2D6** locus in individuals of European ancestry. - In a subcohort of people who co-used cocaine and heroin (speedball users), two haplotypes were also associated with HIV infection; one involved **GPR75** and its ligand **CCL5**, which shares interaction with **CCR5**, an HIV coreceptor. - Authors integrated findings with long-read human pan-genomes to support a model where non-functional copies of **CYP2D6** alter dopaminergic, glutamatergic, and kynurenine pathways, contributing to cocaine use severity. - Replication analyses used de-identified dbGaP data under data-use agreements; study received Rutgers IRB approval and secondary analyses were determined exempt by the Oregon Research Institute IRB. - The source did not report detailed dosing, clinical endpoints, or functional validation experiments; the authors note epistasis detection and structural variant inclusion remain methodological challenges needing further work.
## Clinical Analysis & Structured Key Points
Genetic loci associated with cocaine use identified using a novel approach to detect epistasis | medRxiv Skip to main content Genetic loci associated with cocaine use identified using a novel approach to detect epistasis View ORCID Profile Michael R Garvin , View ORCID Profile Andrew W Bergen , Daniel M Rosenblum , David Kainer , Sharlee Climer , James J Goedert , View ORCID Profile Peter J Attia , Shihui Peng , Qiao Zhang , Stanley H Weiss doi: https://doi.org/10.64898/2026.10.13.26365448 Michael R Garvin 1 Oregon Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Michael R Garvin For correspondence: mgarvin{at}ori.org Andrew W Bergen 1 Oregon Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Andrew W Bergen Daniel M Rosenblum 2 Department of Medicine, Rutgers New Jersey Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site David Kainer 3 ARC Centre of Excellence for Plant Success in Nature and Agriculture, University of Queensland; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sharlee Climer 4 Department of Computer Science, University of Missouri St. Louis; Find this author on Google Scholar Find this author on PubMed Search for this author on this site James J Goedert 5 Anchor Mental Health, Catholic Charities of Washington; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Peter J Attia 6 Rutgers New Jersey Medical School Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Peter J Attia Shihui Peng 2 Department of Medicine, Rutgers New Jersey Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Qiao Zhang 2 Department of Medicine, Rutgers New Jersey Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stanley H Weiss 2 Department of Medicine, Rutgers New Jersey Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background Cocaine use disorder (CUD) is estimated to be 50% heritable, yet few genetic variants have been robustly associated with risk. During January 2021 to June 2024, cocaine was involved in 30% of U.S. overdose deaths. Identifying genetic contributors to CUD could inform diagnostics and treatments. The missing heritability may stem from small sample sizes, models that inadequately account for small-effect common variants, and the exclusion of large-effect structural variants like copy number changes. Epistasis likely contributes but remains challenging to detect genome-wide. Results We focused on epistasis and haplotypes rather than individual SNPs by applying the custom correlation coefficient in BlocBuster to construct allele networks from eQTL SNPs. Testing these regulatory haplotype networks for association with cocaine use in 7,826 individuals with opioid use disorder identified 12 significant associations across two ancestries. For one haplotype, raw genotyping array intensity data revealed a copy number increase at the CYP2D6 locus in individuals of European ancestry. In a subcohort of individuals who co-use cocaine and heroin (i.e., speedball), two haplotypes were also significantly associated with HIV infection. One of these involved GPR75, whose ligand, CCL5 (RANTES), is shared with CCR5, a coreceptor for HIV entry. Conclusions Our findings, integrated with long-read human pan-genomes, support a model in which non-functional copies of CYP2D6 disrupt dopaminergic, glutamatergic, and kynurenine pathways in the brain, contributing to cocaine use severity. The association of additional haplotypes with HIV status in speedball users highlights the genetic contribution to comorbid risk in high-exposure populations. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This research was conducted in line with the principles of the Declaration of Helsinki. Approval was granted by the Rutgers Institutional Review Board (IRB) under protocol Pro20150001314, this protocol initially approved on 17 June 2015 and with continuing reviews approved each year since then. The replication analyses involved secondary analysis of de-identified data obtained from the database of Genotypes and Phenotypes (dbGaP) under authorized data-use agreements. Participants in the contributing dbGaP studies provided informed consent under protocols approved by their respective IRBs. The secondary analyses conducted for the present study were determined that this protocol is exempt from the federal regulations governing protection of human research participants under 45 CFR 46.104(d) by the Oregon Research Institute IRB. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data use to produce these results are available online in the NIH database of genotypes and phenotypes. https://dbgap.ncbi.nlm.nih.gov/home/ Funder Information Declared National Institutes of Health , R01DA050495 New Jersey Commission on Cancer Research , COCR26PPR013 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 14, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Genetic loci associated with cocaine use identified using a novel approach to detect epistasis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Genetic loci associated with cocaine use identified using a novel approach to detect epistasis Michael R Garvin , Andrew W Bergen , Daniel M Rosenblum , David Kainer , Sharlee Climer , James J Goedert , Peter J Attia , Shihui Peng , Qiao Zhang , Stanley H Weiss medRxiv 2026.10.13.26365448; doi: https://doi.org/10.64898/2026.10.13.26365448 Share This Article: Copy Citation Tools Genetic loci associated with cocaine use identified using a novel approach to detect epistasis Michael R Garvin , Andrew W Bergen , Daniel M Rosenblum , David Kainer , Sharlee Climer , James J Goedert , Peter J Attia , Shihui Peng , Qiao Zhang , Stanley H Weiss medRxiv 2026.10.13.26365448; doi: https://doi.org/10.64898/2026.10.13.26365448 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (628) Allergy and Immunology (914) Anesthesia (343) Cardiovascular Medicine (4923) Dentistry and Oral Medicine (488) Dermatology (421) Emergency Medicine (667) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1655) Epidemiology (16115) Forensic Medicine (35) Gastroenterology (1228) Genetic and Genomic Medicine (7167) Geriatric Medicine (740) Health Economics (1079) Health Informatics (5180) Health Policy (1452) Health Systems and Quality Improvement (1807) Hematology (595) HIV/AIDS (1362) Infectious Diseases (except HIV/AIDS) (16396) Intensive Care and Critical Care Medicine (1187) Medical Education (684) Medical Ethics (156) Nephrology (733) Neurology (7435) Nursing (372) Nutrition (1110) Obstetrics and Gynecology (1274) Occupational and Environmental Health (1020) Oncology (3687) Ophthalmology (1077) Orthopedics (400) Otolaryngology (461) Pain Medicine (488) Palliative Medicine (142) Pathology (714) Pediatrics (1837) Pharmacology and Therapeutics (744) Primary Care Research (780) Psychiatry and Clinical Psychology (6032) Public and Global Health (9882) Radiology and Imaging (2479) Rehabilitation Medicine and Physical Therapy (1495) Respiratory Medicine (1258) Rheumatology (654) Sexual and Reproductive Health (791) Sports Medicine (591) Surgery (793) Toxicology (109) Transplantation (313) Urology (299)
## Related Clinical Research

- [Free lunches from drugmakers linked to increased inappropriate prescribing, review finds](https://medichelpline.com/clinical-feed/stat-news-0-stat-pharma-s-free-lunches-for-doctors-boost-inappropriate-prescribing-analysis.md)
- [Argenx Sjögren’s Phase 3 failure and FDA safety flag for evenamide in schizophrenia trials](https://medichelpline.com/clinical-feed/stat-news-2-stat-pharmalittle-we-re-reading-about-a-setback-for-argenx-lilly-suits-over.md)
- [Self-care practices in people with HIV and hypertension or diabetes in LMICs: a systematic review](https://medichelpline.com/clinical-feed/pubmed-42853857.md) (DOI: 10.1371/journal.pone.0360076)
- [Medication adherence tools in Africa: scoping review of methods, validation, and reported rates](https://medichelpline.com/clinical-feed/bmj-open-0-mapping-medication-adherence-tools-in-africa-a-scoping-review.md)
- [Olive oil before carbs and blood sugar: what the mouse study found](https://medichelpline.com/clinical-feed/medical-news-today-0-olive-oil-shot-trend-what-science-really-says-about-fat-and-glucose-response.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.